Cervical clinical trials
ENGOT-cx19 / eVOLVE-Cervical
STATUS: Recruiting
SPONSOR: AstraZeneca
LEAD GROUP: GEICO
ENGOT Model: C
TITLE: A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-centre, Global Study of Volrustomig in Women with High Risk Locally Advanced Cervical Cancer Who Have Not Progressed Following Platinum-based, Concurrent Chemoradiation Therapy (eVOLVE-Cervical)
ClinicalTrials.gov ID: NCT06079671
MaNGO sites (click to see the list)
ENGOT-cx22 / MK-2870-036/TroFuse-036
STATUS: Recruiting
SPONSOR: Merck Sharp & Dohme LLC
LEAD GROUP: BGOG
ENGOT Model: C
TITLE: A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
ClinicalTrials.gov ID: NCT07216703
MaNGO sites (click to see the list)